← Back
Data updated: Mar 10, 2026
INNOPHARMA
OncologyGastroenterology
INNOPHARMA is a generic drug manufacturer focused on Oncology, Gastroenterology.
2020
Since
1
Drugs
-
Trials
5
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PROPOFOL 2025-12-02
PROPOFOL 2025-09-19
Labeling
PROPOFOL 2025-08-12
Labeling
PROPOFOL 2024-08-15
PROPOFOL 2024-06-20
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 70%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 1
Gastroenterology 30%
0 drugs Phase 2: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2020-09-16
- Latest
- 2023-08-31
- Applications
- 1